Characterization of Methylation Patterns in Lung Cancer
NCT02373917 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 683
Last updated 2021-05-04
Summary
In this study the investigators will collect Blood,sputum and saliva samples for Characterization of Methylation Patterns in lung Cancer.
Conditions
Sponsors & Collaborators
-
Nucleix Ltd.
lead INDUSTRY
Principal Investigators
-
Eilon Ganor, MD · Nucleix Ltd.
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-02-28
- Primary Completion
- 2021-04-30
- Completion
- 2021-04-30
Countries
- Israel
Study Locations
More Related Trials
-
Construction and Use of Lung Tumor Microarray for the Analysis of Gene Expression in Lung Cancer
NCT00340847 ·Status: COMPLETED
-
Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
NCT02146170 ·Status: RECRUITING
-
Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site
NCT07325864 ·Status: RECRUITING
-
A Study of Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer
NCT05250817 ·Status: COMPLETED
-
Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
NCT01517971 ·Status: COMPLETED
-
Tumor Molecular Profiling in Early Phase Clinical Trials
NCT04510766 ·Status: RECRUITING
-
Analysis of Brain Metastasis in Patients With Lung Cancer
NCT00071344 ·Status: COMPLETED
-
Enumeration of Circulating Tumour Cells (CTCs) in Patients With Advanced Solid Malignancy Using Complementary Metal Oxide Semiconductor (CMOS) Technology
NCT01596452 ·Status: UNKNOWN
-
Using Infrared Spectroscopy to Analyze Volatile Organic Compounds (VOCs) in the Breath of Patients With Lung Cancer
NCT06288646 ·Status: TERMINATED
-
The Contribution of Induced Glycolysis to the Exhaled Volatile Organic Compounds' (VOCs) Signature in Lung Cancer
NCT01852838 ·Status: UNKNOWN
-
Reveal the Patterns of Presentation, Management and Outcome of Patients With SCLC and Stage III NSCLC in Saudi Arabia:
NCT04836975 ·Status: COMPLETED
-
Study of Proteins in Tumor Samples From Patients With Non-Small Cell Lung Cancer
NCT01415739 ·Status: WITHDRAWN
-
Fluorescence Bronchoscopy and Molecular Characterization of Abnormal Bronchial Lesions: Novel Approaches for Early Detection of Lung Cancer in High Risk Patients
NCT00512642 ·Status: COMPLETED
-
Symptom Collection of Lung Cancer Patients
NCT03384680 ·Status: UNKNOWN
-
Liquid Biopsy Using Methylation Sequencing for Lung Cancer
NCT04253509 ·Status: COMPLETED
-
Investigation of MP Pollution in the Human Respiratory System and Its Relationship to Lung Cancer
NCT06530615 ·Status: ACTIVE_NOT_RECRUITING
-
Developing Novel Circulating Epigenetic Biomarkers for Early Detection of Lung Cancer
NCT04814407 ·Status: RECRUITING
-
Lung Cancer Detection by Measuring Monocyte Activity
NCT02090166 ·Status: UNKNOWN ·Phase: NA
-
Liquid Biopsy in Lung Cancer
NCT03479099 ·Status: COMPLETED
-
Identification of a Plasma Proteomic Signature for Lung Cancer
NCT01752101 ·Status: COMPLETED
-
Immunological Profile Changes In Patients With Advanced Non-Small Cell Lung Cancer
NCT04187768 ·Status: COMPLETED
-
Blood Samples From Patients With Non-Small Cell Lung Cancer and From Healthy Volunteers
NCT00897234 ·Status: COMPLETED
-
Symptom Burden and Unmet Supportive Care Needs in Lung Cancer Patients Undergoing First or Second Line Immunotherapy
NCT03741868 ·Status: COMPLETED
-
Genotyping of Non-small Cell Lung Cancer
NCT02002117 ·Status: UNKNOWN
-
Construction and Evaluation of the Liquid Biopsy-based Early Diagnostic Model for Lung Cancer
NCT04156360 ·Status: UNKNOWN